Effects of antiandrogen-estrogen treatment on sexual and endocrine parameters in hirsute women. 1988

D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
Endocrine Department, Marika Eliadi Hospital, Athens, Greece.

Sexual activity was evaluated in 51 women with hirsutism associated with increased levels of circulating androgens before and while on combined treatment with the antiandrogen cyproterone acetate (CA) and ethinyl estradiol (EE2) and compared to a reference group of 52 subjects. The percentage of unbound testosterone (T) was higher (p less than 0.001), the coital frequency lower (p less than 0.05), and the masturbation frequency higher (p less than 0.04) in hirsute women. Mean frequency of total activity (coitus plus masturbation) was similar in the two groups. Treatment with combination of CA and EE2 resulted in a decline of unbound T (p less than 0.001). There was no change of total sexual activity, but coital frequency increased (p less than 0.05) and masturbation frequency declined (p less than 0.04). It is concluded that raised levels of circulating androgens, as judged by free T concentration, are not of crucial importance in the expression of sexual behavior in hirsute women.

UI MeSH Term Description Entries
D008418 Masturbation Sexual stimulation or gratification of the self. Masturbations
D003075 Coitus The sexual union of a male and a female, a term used for human only. Sexual Intercourse,Coital Frequency,First Intercourse,Coital Frequencies,First Intercourses,Frequencies, Coital,Frequency, Coital,Intercourse, First,Intercourse, Sexual,Intercourses, First
D003534 Cyproterone An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females
D006628 Hirsutism A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
January 1981, Panminerva medica,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
March 1976, The New England journal of medicine,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
January 2015, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
June 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
May 1989, The Journal of clinical endocrinology and metabolism,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
January 1996, Metabolism: clinical and experimental,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
August 1978, Fertility and sterility,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
December 1983, Obstetrics and gynecology,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
January 1991, Acta endocrinologica,
D A Adamopoulos, and S Kampyli, and F Georgiacodis, and N Kapolla, and A Abrahamian-Michalakis
January 1984, Psychotherapy and psychosomatics,
Copied contents to your clipboard!